132 related articles for article (PubMed ID: 16179348)
1. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.
Li X; Hansen PA; Xi L; Chandraratna RA; Burant CF
J Biol Chem; 2005 Nov; 280(46):38317-27. PubMed ID: 16179348
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
[TBL] [Abstract][Full Text] [Related]
3. RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor.
Macchia PE; Jiang P; Yuan YD; Chandarardna RA; Weiss RE; Chassande O; Samarut J; Refetoff S; Burant CF
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E326-31. PubMed ID: 12110538
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Leibowitz MD; Ardecky RJ; Boehm MF; Broderick CL; Carfagna MA; Crombie DL; D'Arrigo J; Etgen GJ; Faul MM; Grese TA; Havel H; Hein NI; Heyman RA; Jolley D; Klausing K; Liu S; Mais DE; Mapes CM; Marschke KB; Michellys PY; Montrose-Rafizadeh C; Ogilvie KM; Pascual B; Rungta D; Tyhonas JS; Urcan MS; Wardlow M; Yumibe N; Reifel-Miller A
Endocrinology; 2006 Feb; 147(2):1044-53. PubMed ID: 16269450
[TBL] [Abstract][Full Text] [Related]
5. The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
Lenhard JM; Lancaster ME; Paulik MA; Weiel JE; Binz JG; Sundseth SS; Gaskill BA; Lightfoot RM; Brown HR
Diabetologia; 1999 May; 42(5):545-54. PubMed ID: 10333046
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
Balasubramanian S; Chandraratna RA; Eckert RL
Carcinogenesis; 2004 Aug; 25(8):1377-85. PubMed ID: 14976133
[TBL] [Abstract][Full Text] [Related]
7. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes.
Rasooly R; Schuster GU; Gregg JP; Xiao JH; Chandraratna RA; Stephensen CB
J Immunol; 2005 Dec; 175(12):7916-29. PubMed ID: 16339527
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
9. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Singh Ahuja H; Liu S; Crombie DL; Boehm M; Leibowitz MD; Heyman RA; Depre C; Nagy L; Tontonoz P; Davies PJ
Mol Pharmacol; 2001 Apr; 59(4):765-73. PubMed ID: 11259621
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
12. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
[TBL] [Abstract][Full Text] [Related]
13. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
[TBL] [Abstract][Full Text] [Related]
14. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
Brown KK; Henke BR; Blanchard SG; Cobb JE; Mook R; Kaldor I; Kliewer SA; Lehmann JM; Lenhard JM; Harrington WW; Novak PJ; Faison W; Binz JG; Hashim MA; Oliver WO; Brown HR; Parks DJ; Plunket KD; Tong WQ; Menius JA; Adkison K; Noble SA; Willson TM
Diabetes; 1999 Jul; 48(7):1415-24. PubMed ID: 10389847
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
16. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
[TBL] [Abstract][Full Text] [Related]
17. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
Yamamoto A; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
[TBL] [Abstract][Full Text] [Related]
18. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation.
Sanz MJ; Albertos F; Otero E; Juez M; Morcillo EJ; Piqueras L
J Immunol; 2012 Jul; 189(1):411-24. PubMed ID: 22661092
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
Montessuit C; Papageorgiou I; Lerch R
Endocrinology; 2008 Mar; 149(3):1064-74. PubMed ID: 18063688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
